Biohaven (EXCHANGE:BHVN) Chief Executive Officer Vlad Coric acquired 666,666 common shares in two transactions on November 13, 2025, at a price of $7.50 per share, for a total value of $4,999,995. The ...
Director Gregory Bailey reported purchasing 400,000 common shares of Biohaven Ltd. (NYSE:BHVN) on November 13, 2025. The shares were acquired at a price of $7.50, for a total transaction value of ...
Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...
The Oxford-Harrington Rare Disease Centre ('OHC') today announced the recipients of the 2025 Rare Disease Scholar Award, which advances promising discoveries from academic labs into clinical practice.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback